Biochemotherapy with thymosin alpha 1, interleukin-2 and dacarbazine in patients with metastatic melanoma: clinical and immunological effects.

M Lopez; S Carpano; R Cavaliere; L Di Lauro; F Ameglio; G Vitelli; A M Frasca; P Vici; F Pignatti; M Rosselli

doi:10.1093/oxfordjournals.annonc.a058979

Biochemotherapy with thymosin alpha 1, interleukin-2 and dacarbazine in patients with metastatic melanoma: clinical and immunological effects.

Identifier:nobleid.org/w1/20260515/7783FD57

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/7783FD57.svg?ark=w1%2F20260515%2F7783FD57)](https://nobleid.org/work/w1/20260515/7783FD57)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Biochemotherapy with thymosin alpha 1, interleukin-2 and dacarbazine in patients with metastatic melanoma: clinical and immunological effects.

Identifier:nobleid.org/w1/20260515/7783FD57

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/7783FD57.svg?ark=w1%2F20260515%2F7783FD57)](https://nobleid.org/work/w1/20260515/7783FD57)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work